Your browser doesn't support javascript.
loading
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
Propper, David J; Gao, Fangfei; Saunders, Mark P; Sarker, Debashis; Hartley, John A; Spanswick, Victoria J; Lowe, Helen L; Hackett, Louise D; Ng, Tony T; Barber, Paul R; Weitsman, Gregory E; Pearce, Sarah; White, Laura; Lopes, Andre; Forsyth, Sharon; Hochhauser, Daniel.
Afiliación
  • Propper DJ; Barts Cancer Institute, Queen Mary, University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Gao F; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Saunders MP; The Christie, Manchester, M20 4BX, UK.
  • Sarker D; School of Cancer and Pharmaceutical Sciences, King's College London, London, WC2R 2LS, UK.
  • Hartley JA; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Spanswick VJ; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Lowe HL; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Hackett LD; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Ng TT; Barts Cancer Institute, Queen Mary, University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • Weitsman GE; Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London, SE1 9RT, UK.
  • Pearce S; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.
  • White L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK.
  • Lopes A; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.
  • Forsyth S; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.
  • Hochhauser D; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.
Br J Cancer ; 128(2): 245-254, 2023 01.
Article en En | MEDLINE | ID: mdl-36352028
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Receptor ErbB-3 Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Receptor ErbB-3 Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido